Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Am J Med Genet A. 2023 Oct;191(10):2640-2646. doi: 10.1002/ajmg.a.63329. Epub 2023 Jun 21.
Floating-Harbor syndrome (FLHS) is a neurodevelopmental disorder (NDD) caused by truncating variants in exons 33 and 34 of the SNF2-related CREBBP activator protein gene (SRCAP). Truncating variants proximal to this location in SRCAP result in a non-FLHS SRCAP-associated NDD; an overlapping but distinct NDD characterized by developmental delay with or without intellectual disability (ID), hypotonia, normal stature, and behavioral and psychiatric issues. Here, we report a young woman who initially presented in childhood with significant delays in speech and mild ID. In young adulthood, she developed schizophrenia. On physical examination, she had facial features suggestive of 22q11 deletion syndrome. After non-diagnostic chromosomal microarray and trio exome sequencing (ES), a re-analysis of trio ES data identified a de novo missense variant in SRCAP that was proximal to the FLHS critical region. Subsequent DNA methylation studies showed the unique methylation signature associated with pathogenic sequence variants in non-FLHS SRCAP-related NDD. This clinical report describes an individual with non-FLHS SRCAP-related NDD caused by an SRCAP missense variant, and it also demonstrates the clinical utility of ES re-analysis and DNA methylation analysis for undiagnosed patients, in particular, those with variants of uncertain significance.
漂浮港综合征(FLHS)是一种神经发育障碍(NDD),由 SNF2 相关 CREBBP 激活蛋白基因(SRCAP)外显子 33 和 34 的截断变异引起。SRCAP 中该位置附近的截断变异导致非 FLHS SRCAP 相关 NDD;一种重叠但不同的 NDD,其特征为发育迟缓伴或不伴智力障碍(ID)、低张力、正常身材以及行为和精神问题。在这里,我们报告了一位年轻女性,她在儿童时期最初表现出言语严重延迟和轻度 ID。在成年早期,她发展为精神分裂症。体格检查时,她具有 22q11 缺失综合征的特征性面部特征。在进行非诊断性染色体微阵列和 trio 外显子组测序(ES)后,对 trio ES 数据的重新分析确定了 SRCAP 中的一个新的错义变异,该变异接近 FLHS 关键区域。随后的 DNA 甲基化研究显示了与非 FLHS SRCAP 相关 NDD 中致病性序列变异相关的独特甲基化特征。本临床报告描述了一个由 SRCAP 错义变异引起的非 FLHS SRCAP 相关 NDD 的个体,还证明了 ES 重新分析和 DNA 甲基化分析对未诊断患者的临床应用价值,特别是对那些具有不确定意义的变异的患者。